
June 11 (Reuters) - Novo Nordisk A/S NOVOb.CO:
NOVO NORDISK SELECTS GEFION AI SUPERCOMPUTER TO ADVANCE DRUG DISCOVERY AND HEALTHCARE INNOVATION
WILL GAIN ACCESS TO GEFION'S COMPUTATIONAL CAPABILITIES TO PROCESS VAST DATASETS
NOVO NORDISK HAS MADE AI A STRATEGIC FOCUS ACROSS ITS VALUE CHAIN AND GEFION WILL PLAY A KEY ROLE IN EXECUTION OF THESE COMPUTE-INTENSIVE PROJECTS
PARTIES SIGN MULTIYEAR AGREEMENT
Further company coverage: [NOVOb.CO]